Related Experiment Video
Updated: Jun 19, 2026

06:59
Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue
Published on: October 12, 2013
Retroperitoneal inflammatory myofibroblastic tumor.
Rabin Koirala1, Vikal C Shakya, Chandra S Agrawal
1Department of Surgery, B. P. Koirala Institute of Health Sciences, Dharan, Nepal.
American Journal of Surgery
|October 20, 2009
Summary
Retroperitoneal inflammatory myofibroblastic tumors are exceptionally rare. This case highlights the surgical excision and histopathologic diagnosis of this uncommon tumor in a rare location.
Area of Science:
- Oncology
- Pathology
Background:
- Inflammatory myofibroblastic tumors (IMT) are uncommon neoplasms.
- Retroperitoneal IMTs represent a rare subset of these tumors.
Observation:
- A 52-year-old male farmer presented with a two-month history of a lower abdominal mass.
- The mass was identified as retroperitoneal in location.
Findings:
- Surgical excision of the retroperitoneal mass was performed.
- Histopathologic examination confirmed the diagnosis of inflammatory myofibroblastic tumor.
Implications:
- This case underscores the importance of considering IMT in the differential diagnosis of retroperitoneal masses.
- Further research into the etiology and optimal management of rare IMT presentations is warranted.
Related Concept Videos
Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...